Olga Guyette | Director, Investor Relations and Treasury |
Chris Simon | Chief Executive Officer |
Stewart Strong | President of Global Hospital Business |
James D'Arecca | Chief Financial Officer |
Anthony Petrone | Mizuho |
Drew Ranieri | Morgan Stanley |
Andrew Cooper | Raymond James |
David Turkaly | JMP Securities |
Mike Matson | Needham & Company |
Good day, and welcome to the Haemonetics Corporation Second Quarter Fiscal 2023 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers' presentation there'll be a question-and-answer session, and instructions will be given at that time.
As a reminder, this call may be recorded. I would now like to turn the call over to Olga Guyette, Senior Director of Investor Relations and Treasury.